secwatch.observer — SEC 8-K summary
======================================

Issuer:     DYNAVAX TECHNOLOGIES CORP (—)
CIK:        0001029142
Form:       8-K
Filed at:   2024-03-12T23:59:59+00:00
Accession:  0000950170-24-029912
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 1.02
LLM model:  deepseek-v4-flash:cloud@v2

Dynavax enters sublease with Metagenomi for 75,662 sq ft after Zymergen bankruptcy
--------------------------------------------------------------------------------

- Zymergen sublease terminated via Termination Agreement approved by bankruptcy court on Feb 22, 2024.
- New sublease with Metagenomi for entire premises at 5959 Horton St, Emeryville, initial monthly rent $493,354.
- Rent abated 50% through June 30, 2024; term runs through March 31, 2031, concurrent with master lease.
- Master Landlord consented on March 7, 2024; Sublease to be filed with Q1 2024 10-Q.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/0000950170-24-029912-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1029142/000095017024029912/dvax-20240307.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-029912

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer